A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61K 38/00 (2006.01) A61K 38/20 (2006.01) C07K 14/545 (2006.01) C07K 14/715 (2006.01) C07K 16/24 (2006.01) C12P 21/02 (2006.01)
Patent
CA 2039458
73605-14 Abstract of the Invention Disclosed are medicines for treating interleukin-1 mediated diseases including interleukin-1 mediated arthritis, interleukin-1 mediated inflammatory bowel disease, interleukin-1 mediated septic shock, interleukin-1 mediated ischemia injury, and interleukin-1 mediated reperfusion injury. The medicine com- prises a therapeutically effective amount of an interleukin-1 inhibitor. In a preferred embodiment, the interleukin inhibitor is selected from the group consisting of IL-lraa, IL-lraB, IL-lrax, and a combination thereof. A preferred method of produc- ing IL-lraa, IL-lraB, Il-lrax is by recombinant DNA technology.
Carmichael David F.
Smith Christopher G.
Thompson Robert C.
Amgen Inc.
Smart & Biggar
LandOfFree
Methods for treating interleukin-1 mediated diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating interleukin-1 mediated diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating interleukin-1 mediated diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1868537